These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20008786)

  • 21. A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis.
    Wamhoff BR; Hoofnagle MH; Burns A; Sinha S; McDonald OG; Owens GK
    Circ Res; 2004 Nov; 95(10):981-8. PubMed ID: 15486317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation.
    Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mesenchymal Stem Cells Stimulated by Growth Factors Release Exosomes with Potent Proangiogenic Activity].
    Bian SY; Liu HB; Liu HW; Zhu QW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1538-1542. PubMed ID: 30295280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell.
    Arita Y; Kihara S; Ouchi N; Maeda K; Kuriyama H; Okamoto Y; Kumada M; Hotta K; Nishida M; Takahashi M; Nakamura T; Shimomura I; Muraguchi M; Ohmoto Y; Funahashi T; Matsuzawa Y
    Circulation; 2002 Jun; 105(24):2893-8. PubMed ID: 12070119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein tyrosine phosphatase SHP-2 is positively involved in platelet-derived growth factor-signaling in vascular neointima formation via the reactive oxygen species-related pathway.
    Won KJ; Lee HM; Lee CK; Lin HY; Na H; Lim KW; Roh HY; Sim S; Song H; Choi WS; Lee SH; Kim B
    J Pharmacol Sci; 2011; 115(2):164-75. PubMed ID: 21343667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells.
    Faraone D; Aguzzi MS; Ragone G; Russo K; Capogrossi MC; Facchiano A
    Blood; 2006 Mar; 107(5):1896-902. PubMed ID: 16322476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
    Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation.
    Pires NM; Pols TW; de Vries MR; van Tiel CM; Bonta PI; Vos M; Arkenbout EK; Pannekoek H; Jukema JW; Quax PH; de Vries CJ
    Circulation; 2007 Jan; 115(4):493-500. PubMed ID: 17242285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat.
    Ruef J; Meshel AS; Hu Z; Horaist C; Ballinger CA; Thompson LJ; Subbarao VD; Dumont JA; Patterson C
    Circulation; 1999 Aug; 100(6):659-65. PubMed ID: 10441105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells.
    Chadjichristos CE; Morel S; Derouette JP; Sutter E; Roth I; Brisset AC; Bochaton-Piallat ML; Kwak BR
    Circ Res; 2008 Mar; 102(6):653-60. PubMed ID: 18239136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle.
    Tharp DL; Wamhoff BR; Turk JR; Bowles DK
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2493-503. PubMed ID: 16798818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways.
    Iijima K; Yoshizumi M; Hashimoto M; Akishita M; Kozaki K; Ako J; Watanabe T; Ohike Y; Son B; Yu J; Nakahara K; Ouchi Y
    Circulation; 2002 May; 105(20):2404-10. PubMed ID: 12021228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of human smooth muscle cell proliferation by thrombin involves increased synthesis of platelet-derived growth factor.
    Bydlowski SP; Pares MM; Soares RP; Lopes AA
    Chest; 1998 Jul; 114(1):236-40. PubMed ID: 9674475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epothilone D, a microtubule-stabilizing compound, inhibits neointimal hyperplasia after rat carotid artery injury by cell cycle arrest via regulation of G1-checkpoint proteins.
    Kim TJ; Lim Y; Kim DW; Kwon JS; Son JH; Jin YR; Son DJ; Jung JC; Avery MA; Hong JT; Yun YP
    Vascul Pharmacol; 2007 Oct; 47(4):229-37. PubMed ID: 17706465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries.
    Tang Z; Wang Y; Fan Y; Zhu Y; Chien S; Wang N
    Circulation; 2008 Aug; 118(7):764-72. PubMed ID: 18663086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides.
    Wang W; Chen HJ; Schwartz A; Cannon PJ; Stein CA; Rabbani LE
    J Clin Invest; 1996 Jul; 98(2):443-50. PubMed ID: 8755655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arachidonic acid pretreatment enhances smooth muscle cell migration via increased Ca2+ influx.
    Kanayasu-Toyoda T; Morita I; Murota S
    Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):25-31. PubMed ID: 9482163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: relationships to neointima formation.
    Wong J; Rauhöft C; Dilley RJ; Agrotis A; Jennings GL; Bobik A
    Circulation; 1997 Sep; 96(5):1631-40. PubMed ID: 9315558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.